Direct Observation of the Three Regions in α-Synuclein that Determine its Membrane-Bound Behaviour

α-synuclein (αS) is a protein involved in neurotransmitter release in presynaptic terminals, and whose aberrant aggregation is associated with Parkinson’s disease. In dopaminergic neurons, αS exists in a tightly regulated equilibrium between water-soluble and membrane-associated forms. Here we used a combination of solid-state and solution-state NMR spectroscopy to characterize the conformations of αS bound to lipid membranes mimicking the composition and physical properties of synaptic vesicles. The study evidences three αS regions possessing distinct structural and dynamical properties, including an N-terminal helical segment having a role of membrane-anchor, an unstructured C-terminal region that is weakly associated with the membrane, and a central region acting as a sensor of the lipid properties and determining the affinity of αS membrane binding. Taken together, our data define the nature of the interactions of αS with biological membranes and provide insights into their roles in the function and in the molecular processes leading the aggregation of this protein.

[1]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[2]  O. Pongs,et al.  Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR , 2006, Nature.

[3]  B. Meier,et al.  Structural and functional characterization of two alpha-synuclein strains , 2013, Nature Communications.

[4]  A. Watts,et al.  Observations of light-induced structural changes of retinal within rhodopsin , 2000, Nature.

[5]  G. Melacini,et al.  Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. , 2007, Journal of the American Chemical Society.

[6]  L. Brown,et al.  Solid-state NMR spectroscopy structure determination of a lipid-embedded heptahelical membrane protein , 2013, Nature Methods.

[7]  Vladimir N Uversky,et al.  Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. , 2009, Current protein & peptide science.

[8]  C. Rienstra,et al.  Structural intermediates during α-synuclein fibrillogenesis on phospholipid vesicles. , 2012, Journal of the American Chemical Society.

[9]  B. Meier,et al.  Solid-state NMR sequential assignments of α-synuclein , 2011, Biomolecular NMR Assignments.

[10]  Songi Han,et al.  Hydration dynamics as an intrinsic ruler for refining protein structure at lipid membrane interfaces , 2013, Proceedings of the National Academy of Sciences.

[11]  Monika Fuxreiter,et al.  Fuzziness: linking regulation to protein dynamics. , 2012, Molecular bioSystems.

[12]  A. Bax,et al.  Comparison of Structure and Dynamics of Micelle-bound Human α-Synuclein and Parkinson Disease Variants* , 2005, Journal of Biological Chemistry.

[13]  G. Veglia,et al.  Topology and immersion depth of an integral membrane protein by paramagnetic rates from dissolved oxygen , 2011, Journal of biomolecular NMR.

[14]  T. Ulmer,et al.  α-Synuclein Populates Both Elongated and Broken Helix States on Small Unilamellar Vesicles , 2011, The Journal of Biological Chemistry.

[15]  R. Perrin,et al.  Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. , 2000, The Journal of biological chemistry.

[16]  S. Becker,et al.  Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Guifang Wang,et al.  19F NMR studies of alpha-synuclein conformation and fibrillation. , 2009, Biochemistry.

[18]  Ad Bax,et al.  Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.

[19]  Ralf Langen,et al.  A combinatorial NMR and EPR approach for evaluating the structural ensemble of partially folded proteins. , 2010, Journal of the American Chemical Society.

[20]  Ad Bax,et al.  Impact of N-Terminal Acetylation of α-Synuclein on Its Random Coil and Lipid Binding Properties , 2012, Biochemistry.

[21]  David L. Worcester,et al.  Structure and hydration of membranes embedded with voltage-sensing domains , 2009, Nature.

[22]  Nicolas L. Fawzi,et al.  Atomic resolution dynamics on the surface of amyloid β protofibrils probed by solution NMR , 2011, Nature.

[23]  C. Dobson Protein folding and misfolding , 2003, Nature.

[24]  P. Lansbury,et al.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.

[25]  J. Nagle,et al.  Structure of lipid bilayers. , 2000, Biochimica et biophysica acta.

[26]  G. Veglia,et al.  Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban , 2013, Proceedings of the National Academy of Sciences.

[27]  A. Leftin,et al.  Solid-state ¹³C NMR reveals annealing of raft-like membranes containing cholesterol by the intrinsically disordered protein α-Synuclein. , 2013, Journal of molecular biology.

[28]  L. Kay,et al.  Studying "invisible" excited protein states in slow exchange with a major state conformation. , 2012, Journal of the American Chemical Society.

[29]  P. Tompa,et al.  Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. , 2008, Trends in biochemical sciences.

[30]  K. Takegoshi,et al.  13C-1H dipolar recoupling under very fast magic-angle spinning using virtual pulses. , 1999, Solid State Nuclear Magnetic Resonance.

[31]  Nathaniel J. Traaseth,et al.  Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach , 2009, Proceedings of the National Academy of Sciences.

[32]  Gareth A. Morris,et al.  Enhancement of nuclear magnetic resonance signals by polarization transfer , 1979 .

[33]  C. Dobson,et al.  Differential Phospholipid Binding of α-Synuclein Variants Implicated in Parkinson’s Disease Revealed by Solution NMR Spectroscopy† , 2009, Biochemistry.

[34]  B. Meier,et al.  Yet another polymorph of α-synuclein: solid-state sequential assignments , 2014, Biomolecular NMR assignments.

[35]  Bernard Schneider,et al.  α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer* , 2012, The Journal of Biological Chemistry.

[36]  Seung-Jae Lee,et al.  Membrane-bound α-Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form* , 2002, The Journal of Biological Chemistry.

[37]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Monika Fuxreiter,et al.  Fuzzy complexes: a more stochastic view of protein function. , 2012, Advances in experimental medicine and biology.

[39]  Lisa D. Cabrita,et al.  In-Cell NMR Characterization of the Secondary Structure Populations of a Disordered Conformation of α-Synuclein within E. coli Cells , 2013, PloS one.

[40]  Ralf Langen,et al.  Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement , 2008, Proceedings of the National Academy of Sciences.

[41]  V. Subramaniam,et al.  Dependence of alpha-synuclein aggregate morphology on solution conditions. , 2002, Journal of molecular biology.

[42]  C. Dobson,et al.  Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. , 2005, Journal of the American Chemical Society.

[43]  D. Selkoe,et al.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation , 2011, Nature.

[44]  D. Eliezer,et al.  Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.

[45]  Christopher M Dobson,et al.  α-Synuclein Senses Lipid Packing Defects and Induces Lateral Expansion of Lipids Leading to Membrane Remodeling* , 2013, The Journal of Biological Chemistry.

[46]  V. Subramaniam,et al.  Dependence of α-synuclein aggregate morphology on solution conditions , 2002 .

[47]  Ad Bax,et al.  Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. , 2009, Journal of molecular biology.

[48]  V. Uversky,et al.  Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.

[49]  M. Vendruscolo,et al.  The A53T mutation is key in defining the differences in the aggregation kinetics of human and mouse α-synuclein. , 2011, Journal of the American Chemical Society.

[50]  Guifang Wang,et al.  19F NMR studies of α‐synuclein‐membrane interactions , 2010, Protein science : a publication of the Protein Society.

[51]  T. Nagatsu [Biochemistry of Parkinson's disease]. , 1988, Seikagaku. The Journal of Japanese Biochemical Society.

[52]  Vladimir N Uversky,et al.  Α-synuclein misfolding and Parkinson's disease. , 2012, Biochimica et biophysica acta.

[53]  Vladimir N Uversky,et al.  A Protein-Chameleon: Conformational Plasticity of α-Synuclein, a Disordered Protein Involved in Neurodegenerative Disorders , 2003, Journal of biomolecular structure & dynamics.

[54]  Carlo Camilloni,et al.  Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts. , 2012, Biochemistry.

[55]  G. Melacini,et al.  Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. , 2007, Journal of the American Chemical Society.

[56]  Cinque S. Soto,et al.  Structure of the Amantadine Binding Site of Influenza M2 Proton Channels In Lipid Bilayers , 2010, Nature.

[57]  H. Jäckle,et al.  Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease models , 2009, The EMBO journal.